<DOC>
	<DOC>NCT00803270</DOC>
	<brief_summary>The purpose of this study is to compare treatment outcomes for patients with mixed urinary incontinence (MUI) for whom therapy is initiated with surgery to those for whom therapy is initiated with non-surgical treatment. Women who are bothered by symptoms of both stress and urge incontinence will be randomly assigned to initiate treatment with a surgical (surgery for stress incontinence) vs. a non-surgical (drug and behavioral therapy) approach. Follow-up will be a minimum of 12 Months.</brief_summary>
	<brief_title>Mixed Incontinence: Medical Or Surgical Approach?</brief_title>
	<detailed_description>The purpose of this study is to compare treatment outcomes for patients with mixed urinary incontinence (MUI) for whom therapy is initiated with surgery to those for whom therapy is initiated with non-surgical treatment. Women who are bothered by symptoms of both stress and urge incontinence will be randomly assigned to initiate treatment with a surgical (surgery for stress incontinence) vs. a non-surgical (drug and behavioral therapy) approach. Follow-up will be a minimum of 12 Months.</detailed_description>
	<mesh_term>Urinary Incontinence</mesh_term>
	<mesh_term>Enuresis</mesh_term>
	<criteria>1. Female 2. Mixed UI as evidenced by stress and urge symptoms reported on MESA (either percent of urgetype symptoms ≥ the percent of stresstype symptoms or urge symptom score ≥7 if stress predominant) followed by report of "moderately" or "greatly"/"quite a bit" bothered to questions 2 and 3 of the 6item Urinary Distress Index (UDI6) or questions 16 and 17 of the 20item Pelvic Fl;oor Distress Index (PFDI20), respectively (See Appendix C) 3. Moderate or severe UI as evidenced by the corresponding response on the Patient Global Impression of Severity (PGIS) 4. Incontinence symptoms present for at least (3) months* 5. Bladder capacity &gt; 200cc (by any method) 6. Urodynamic Stress Incontinence 7. Eligible for both treatment interventions 8. Available to start intervention within 6 weeks 9. Negative urine dipstick (negative result = trace or less for leukocytes &amp; nitrites) 10. Available for 12 months of followup and able to complete study assessments as per clinician judgment 11. Signed consent form 1. Age &lt;21 years* 2. Currently undergoing or recommended to undergo treatment of pelvic organ prolapse 3. Other indicated/planned concomitant surgery 4. Pregnant or has not completed child bearing* 5. &lt;12 months postpartum*† 6. Active malignancy of cervix, uterus, fallopian tube(s) or ovary &gt; Stage I, or bladder of any Stage 7. Current catheter use 8. Unevaluated hematuria 9. Participation in another trial that may influence the results of this study Patient can be rescreened after respective time interval has been met. †"Partum" is defined as a delivery or other termination that occurs after 20 weeks gestation.</criteria>
	<gender>Female</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Stress urinary incontinence, Mixed, Urge</keyword>
</DOC>